vindesine has been researched along with Pleural Effusion, Malignant in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyazawa, N; Yokoi, K | 1 |
Akiyama, Y; Fujii, Y; Kondo, H; Shirono, R | 1 |
Li, D; Wu, Z; Zhang, Z | 1 |
1 trial(s) available for vindesine and Pleural Effusion, Malignant
Article | Year |
---|---|
[Treatment of malignant pleural effusion using vindesine and cisplatine intrapleurally injection (observation of 60 cases)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Routes; Drug Tolerance; Female; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Survival Rate; Vindesine | 2001 |
2 other study(ies) available for vindesine and Pleural Effusion, Malignant
Article | Year |
---|---|
Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurisy; Pneumonectomy; Survival Rate; Vindesine | 1996 |
[A case of lung adenocarcinoma associated with remarkably high levels of CA 19-9 and lymphangitis carcinomatosa].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Cisplatin; Humans; Lung Neoplasms; Lymphangitis; Male; Pleural Effusion, Malignant; Vindesine | 1997 |